On Tuesday, Humana Inc (NYSE: HUM) opened lower -1.92% from the last session, before settling in for the closing price of $256.69. Price fluctuations for HUM have ranged from $213.31 to $406.46 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 12.71% over the past five years. Company’s average yearly earnings per share was noted 0.92% at the time writing. With a float of $120.43 million, this company’s outstanding shares have now reached $120.69 million.
Let’s look at the performance matrix of the company that is accounted for 65680 employees. In terms of profitability, gross margin is 100.0%, operating margin of 2.78%, and the pretax margin is 1.94%.
Humana Inc (HUM) Insider Updates
A key investor’s attitude towards the stock of the Healthcare Plans industry is another important factor to consider. The insider ownership of Humana Inc is 0.22%, while institutional ownership is 97.24%. The most recent insider transaction that took place on Apr 08 ’25, was worth 2,732,134. Before that another transaction happened on Feb 24 ’25, when Company’s Former Chief Administrative Of proposed sale 1,247 for $258.58, making the entire transaction worth $322,443.
Humana Inc (HUM) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 0.92% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.90% during the next five years compared to -13.05% drop over the previous five years of trading.
Humana Inc (NYSE: HUM) Trading Performance Indicators
Check out the current performance indicators for Humana Inc (HUM). In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 12.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 14.14, a number that is poised to hit 5.99 in the next quarter and is forecasted to reach 14.55 in one year’s time.
Technical Analysis of Humana Inc (HUM)
Humana Inc (NYSE: HUM) saw its 5-day average volume 1.86 million, a positive change from its year-to-date volume of 1.67 million. As of the previous 9 days, the stock’s Stochastic %D was 18.40%. Additionally, its Average True Range was 11.06.
During the past 100 days, Humana Inc’s (HUM) raw stochastic average was set at 26.60%, which indicates a significant increase from 17.03% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.37% in the past 14 days, which was higher than the 44.60% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $265.02, while its 200-day Moving Average is $289.63. Nevertheless, the first resistance level for the watch stands at $256.25 in the near term. At $260.73, the stock is likely to face the second major resistance level. The third major resistance level sits at $263.46. If the price goes on to break the first support level at $249.04, it is likely to go to the next support level at $246.31. Assuming the price breaks the second support level, the third support level stands at $241.83.
Humana Inc (NYSE: HUM) Key Stats
There are currently 120,693K shares outstanding in the company with a market cap of 30.39 billion. Presently, the company’s annual sales total 117,761 M according to its annual income of 1,207 M. Last quarter, the company’s sales amounted to 32,112 M and its income totaled 1,244 M.
